Radiobiology of radioimmunother... [Int J Radiat Oncol Biol Phys. 2004] - PubMed

loading

[Radioimmunotherapy in non-Hodgkin's lymphoma. With focus on anti-CD20 treatment]. [Ugeskr Laeger. 2005]
[Radioimmunotherapy in non-Hodgkin's lymphoma. With focus on anti-CD20 treatment].
de Nully Brown P, Jurlander J, Lindén O, Hansen M. Ugeskr Laeger. 2005 Oct 10; 167(41):3867-9.
Review Radiobiology of radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin). [Semin Oncol. 2003]
Review Radiobiology of radioimmunotherapy with 90Y ibritumomab tiuxetan (Zevalin).
Hernandez MC, Knox SJ. Semin Oncol. 2003 Dec; 30(6 Suppl 17):6-10.
Review Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma. [Oncology (Williston Park). 2004]
Review Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma.
Ghobrial I, Witzig T. Oncology (Williston Park). 2004 May; 18(5):623-30; discussion 633-4, 637-8, 640.
Review Clinical development of radioimmunotherapy for B-cell non-Hodgkin's lymphoma. [Int J Radiat Oncol Biol Phys. ...]
Review Clinical development of radioimmunotherapy for B-cell non-Hodgkin's lymphoma.
Meredith RF, Knox SJ. Int J Radiat Oncol Biol Phys. 2006; 66(2 Suppl):S15-22.
It is follicular... . so, why CHOP? [J Clin Oncol. 2007]
It is follicular... . so, why CHOP?
Nabhan C. J Clin Oncol. 2007 Mar 1; 25(7):915-6; author reply 916-7.

Review Cancer radioimmunotherapy. [Immunotherapy. 2011]
Review Cancer radioimmunotherapy.
Sharkey RM, Goldenberg DM. Immunotherapy. 2011 Mar; 3(3):349-70.
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma. [Eur J Nucl Med Mol Imaging. 2011]
Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin's lymphoma.
Roberson PL, Amro H, Wilderman SJ, Avram AM, Kaminski MS, Schipper MJ, Dewaraja YK. Eur J Nucl Med Mol Imaging. 2011 May; 38(5):874-83. Epub 2010 Dec 21.
Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy. [J Nucl Med. 2010]
Methodology to incorporate biologically effective dose and equivalent uniform dose in patient-specific 3-dimensional dosimetry for non-Hodgkin lymphoma patients targeted with 131I-tositumomab therapy.
Amro H, Wilderman SJ, Dewaraja YK, Roberson PL. J Nucl Med. 2010 Apr; 51(4):654-9. Epub 2010 Mar 17.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin...
Radiobiology of radioimmunotherapy: targeting CD20 B-cell antigen in non-Hodgkin's lymphoma.
Int J Radiat Oncol Biol Phys. 2004 Aug 1 ;59(5):1274-87.

PubMed
Wilson's disease: the problem of delayed diagnosis.
Wilson's disease: the problem of delayed diagnosis.
J Neurol Neurosurg Psychiatry. 1992 Aug ;55(8):692-6.

PubMed
Immune evasion by Babesia bovis and Plasmodium falciparum: cliff-dwellers of the...
Immune evasion by Babesia bovis and Plasmodium falciparum: cliff-dwellers of the parasite world.
Parasitol Today. 1995 Mar ;11(3):100-5.

PubMed
Glycoconjugates are stage- and position-specific cell surface molecules in the d...
Glycoconjugates are stage- and position-specific cell surface molecules in the developing olfactory system, 2: Unique carbohydrate antigens are topographic markers for selective projection patterns of olfactory axons.
J Neurobiol. 1992 Mar ;23(2):130-42.

PubMed
Schools for health: Focus on health, education and the school-age child.
Schools for health: Focus on health, education and the school-age child.
Parasitol Today. 1996 Aug ;12(8):suppl 1-16.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed